Literature DB >> 16231509

[Renal hyperparathyroidism's control after subtotal parathyroidectomy].

E Jiménez Víbora1, N Aresté, M Salgueira, N del Toro, A Jiménez García, J L Villar, A Palma.   

Abstract

UNLABELLED: Parathyroidectomy, in any of its forms, is considered an effective short-term treatment of renal hyperparathyroidism in patients who are not being controlled with drugs. Nevertheless, the outcome in the medium and long term of the various surgical procedures is still unclear and seems a controversial issue. We conducted a prospective study of 15 patients undergoing subtotal parathyroidectomy who were followed up for a period of 48 months after surgery. All patients were included in hemodialysis programmes. Elevated levels of parathyroid hormone which did not decrease with drug therapy recommended parathyroidectomy. The aim of our study is to determine whether subtotal parathyroidectomy is an effective technique in the medium and long term. As regards the results obtained, the levels of parathyroid hormone and calcemia remarkably decreased during the follow-up period, if compared to pre-surgery levels. The level of alkaline phosphatase also showed a reduction and the "hungry bone effect" was observed. The phosphorus and Ca-P product levels only showed a significant reduction immediately after surgery but showed an increment from the first year after surgery onwards. Hemoglobin levels did not show any alteration after parathyroidectomy. In two patients we observed a relapse of hyperparathyroidism. The anatomopathological examination revealed nodular hyperplasia in most of the cases, including the two relapses.
CONCLUSION: Subtotal parathyroidectomy is an effective surgical procedure in the medium-term treatment of renal hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231509

Source DB:  PubMed          Journal:  Nefrologia        ISSN: 0211-6995            Impact factor:   2.033


  1 in total

1.  Surgical Outcomes of Subtotal Parathyroidectomy for Renal Hyperparathyroidism.

Authors:  Min Song Kim; Gheun-Ho Kim; Chang Hwa Lee; Joon-Sung Park; Ji Young Lee; Kyung Tae
Journal:  Clin Exp Otorhinolaryngol       Date:  2020-02-21       Impact factor: 3.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.